Perspective Therapeutics, Inc. Quarterly Depreciation in USD from Q3 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Perspective Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q3 2014 to Q1 2024.
  • Perspective Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $346K, a 92.2% increase year-over-year.
  • Perspective Therapeutics, Inc. annual Depreciation for 2023 was $946K, a 254% increase from 2022.
  • Perspective Therapeutics, Inc. annual Depreciation for 2022 was $267K, a 79.2% increase from 2021.
  • Perspective Therapeutics, Inc. annual Depreciation for 2021 was $149K, a 1.36% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $346K +$166K +92.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $180K +$116K +181% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q3 2022 $68K +$9K +15.3% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q1 2022 $64K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 $59K +$25K +73.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q3 2020 $34K -$4K -10.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q3 2019 $38K +$6K +18.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q3 2018 $32K +$14K +77.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q3 2017 $18K +$2K +12.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q3 2016 $16K -$121K -88.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q4 2015 $138K +$2.36K +1.74% Oct 1, 2015 Dec 31, 2015 10-Q 2016-02-09
Q3 2015 $137K -$33.3K -19.6% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-09
Q4 2014 $135K Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 $170K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.